Clinical Trial

Zimmer Biomet Shoulder Arthroplasty PMCF

Recruiting
View on ClinicalTrials.gov →
Summary
The objectives of this study are to confirm the safety, performance, and clinical benefits of Zimmer Biomet Shoulder Arthroplasty Systems and its instrumentation in primary or revision shoulder arthroplasty. These objectives will be assessed using standard scoring systems, radiographic evidence, and adverse event records. Safety of the system will be assessed by monitoring the frequency an incidence of adverse events.
Protocol Amendment History 15 amendments
This ClinicalTrials.gov record has been amended 15 times since 2021-07-29; most recent amendment 2026-04-22.
Status change: Not Yet Recruiting → Recruiting 2021-09-21
Trial Details
NCT Number NCT04984291
Lead Sponsor Zimmer Biomet
Conditions Shoulder Fractures, Shoulder Arthritis, Shoulder Osteoarthritis, Shoulder Deformity, Shoulder Injuries, Shoulder Pain
Enrollment 584 participants
Start Date 2021-07-28
Primary Completion 2033-08-15 (estimated)
Study Completion 2033-08-15 (estimated)
Updated on ClinicalTrials.gov 2026-04-28